About | HeinOnline Law Journal Library | HeinOnline Law Journal Library | HeinOnline

LOG IN
LOG IN


5 Scholar 111 (2002-2003)
Pharmacogenomics: A Brave New World in Designer Drugs

handle is hein.journals/schom5 and id is 117 raw text is: PHARMACOGENOMICS: A BRAVE NEW WORLD IN DESIGNER DRUGS* DEE MARLO E. CHICOt I. Introduction ............................................... 112 A. Laying the Foundation ................................ 113 1. The Scientific Background ........................ 115 2. An Introduction to Pharmacogenomics ............ 116 II. Historical Perspective: An Introduction to Pharm acogenom ics ........................................ 122 A. The Genome and Human History ..................... 124 B. Genetic Determinism and Discrimination ............. 125 C. The Shadow of Eugenics .............................. 126 D. The Nature of Pharmacogenomics ..................... 129 III. A nalysis ................................................... 130 A. Genetics and the Law ................................. 130 1. State Legislation .................................. 133 a. Genetic Laws in General ...................... 135 * The title alludes to Aldous Huxley's dystopia in Brave New World. ALDOUS HUXLEY, BRAVE NEW WORLD (1932). In his novel, science has become the panacea for many of society's ills; thus, its techniques and philosophies have been applied to every facet of human life. Eugenics has triumphed to the point where babies, according to the needs of society, are decanted. See generally id. (describing the decanting process; this author sees it as homologous to baking and animal husbandry). Although a rather controlled and emotionless vision of the future, Huxley portrays the ills of science and technology in his society with the underlying themes of community, identity, and stability. Id. at 1 (referring to the motto for Huxley's utopian World State: Community, Identity, Stability). Just as this comment inquires into those ills that may destroy mankind, it also explores how science, specifically in the field of pharmacogenomics, may improve the caliber of human beings. t St. Mary's School of Law, Candidate for J.D, May 2003. St. Edward's University, B.S., Biology, May 1998. I would like to thank God for giving me the strength and perseverance to complete this comment. To my parents, Daniel and Norma, and brother, Neil Edward, thank you for your love and guidance. To my sister, Diane, thank you for your encouragement, support, and input - especially all things scientific. To The Scholar Team who worked on my comment, thank you for your suggestions. They were greatly appreciated. For their guidance in drafting and editing, I would like to thank my editors, Jon Michael Hayes and Yvette Aguilar, who made this publication possible through their hard work. Finally, many thanks to Platz and Strausse for their friendship, encouragement, and insanity.